GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: CM-082 | CM082 | Example 8 [WO2008033562A2] | EYP-1901 | X-82
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Vorolanib (CM082) is a potent and selective, oral clinical stage multi-kinase inhibitor. Targets include all VEGFR isoforms, PDGFR and CSF1R. [1-3]. It is a structural derivative of sunitinib. Vorolanib has anti-angiogenic activity, and is being investigated for anti-tumour effects and utility to treat ocular neovascularisation.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
IUPAC Name ![]()  | 
                                                        
| N-[(3S)-1-(dimethylcarbamoyl)pyrrolidin-3-yl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 10338 | vorolanib | 
Synonyms ![]()  | 
                                                        
| CM-082 | CM082 | Example 8 [WO2008033562A2] | EYP-1901 | X-82 | 
Database Links ![]()  | 
                                                        |
| CAS Registry No. | 1013920-15-4 (source: WHO INN record) | 
| ChEMBL Ligand | CHEMBL4297587 | 
| DrugBank Ligand | DB15247 | 
| GtoPdb PubChem SID | 442878652 | 
| PubChem CID | 59215954 | 
| Search Google for chemical match using the InChIKey | KMIOJWCYOHBUJS-HAKPAVFJSA-N | 
| Search Google for chemicals with the same backbone | KMIOJWCYOHBUJS | 
| Search PubMed clinical trials | vorolanib | 
| Search PubMed titles | vorolanib | 
| Search PubMed titles/abstracts | vorolanib | 
| UniChem Compound Search for chemical match using the InChIKey | KMIOJWCYOHBUJS-HAKPAVFJSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | KMIOJWCYOHBUJS-HAKPAVFJSA-N | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖